Navigation Links
Winnick Family Clinical Research Center Celebrates 6th Anniversary
Date:3/3/2008

Center's Innovative Research Program Continues to Draw Accolades from

Cedars-Sinai Medical Community

LOS ANGELES, March 3 /PRNewswire/ -- The Winnick Family Clinical Research Center celebrated its sixth anniversary this month and announced that it has 60 active research protocols at the Center in 2008, representing 210 clinical researchers at Cedars-Sinai Medical Center. These researchers are active in areas ranging from women's health and the genetics of common diseases to mitochondrial genetics, insulin resistance and AIDS. The Winnick Family Foundation, founded by business visionary Gary Winnick, funds the Winnick Family Clinical Research Center at Cedars-Sinai Medical Center and the critical research that takes place at its facility.

"We continue to be hugely encouraged and inspired in our research by the generous support from the Winnick Family Foundation," said Dr. Shlomo Melmed, senior vice president academic affairs of Cedars-Sinai Medical Center. "With the breakthroughs in genetic research now coming faster and gaining in practical medical relevance all the time, the generous donations made to our genetic research programs by Gary Winnick through his foundation to the Winnick Family Clinical Research Center are enabling us to explore whole new treatment protocols with the potential to improve quality of life and life expectancy for thousands of patients suffering from a wide spectrum of illnesses. We look forward to continuing our dynamic relationship with Gary and the Winnick Family Foundation for many years to come."

"It's been an honor for us to make a contribution toward the immensely important research work being carried out at Cedars-Sinai," said Gary Winnick, founder and president of the Winnick Family Foundation. "Since the beginning of our relationship with the Center, it was crucial that the innovative, exciting work being carried out with the support of the Winnick Family Foundation give special emphasis to patient-oriented research. We are confident that this is the cutting-edge of clinical research. Our hopes have been amply rewarded by the Center's groundbreaking research into some of the afflictions that are among the greatest scourges of our society. It's wonderful to see young, gifted scientists taking up the torch of pioneering research in the Human Genome era, and we can't wait to see what the 2008 Winnick Clinical Scholars and larger body of researchers at the Winnick Family Clinical Research Center will be working on over the coming year."

The Winnick Family Clinical Research Center is a fully staffed center for clinical research active in all major clinical departments, utilizing administration, nursing, and nutritional support, along with core laboratory services in sample processing, tissue culture, genome screening and bioinformatics.


'/>"/>
SOURCE Winnick Family Clinical Research Center
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. IsoTis Receives FDA Clearance for Accell Family of Products
2. Cardica and Cook Sign Agreement to Expand Cook Vascular Closure Device Product Family
3. Melanoma Research Foundation and Seattle Cancer Care Alliance Host Educational Symposium and Reception for Melanoma Patients, Family Members and Healthcare Providers
4. Chindexs United Family Hospitals and Clinics and NBC Enter into Healthcare Services Agreement
5. Dr. Charles A. Sims of California Cryobanks Family Cord Blood Services Named to National Stem Cell Advisory Council
6. Vaccines are Likely to Cause Insulin Dependent Diabetes in Over 2% of Children With a Strong Family History of Insulin Dependent Diabetes, New Data Indicates
7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
9. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
10. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
11. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... , ... March 21, 2017 , ... ... , more than tripling its goal and raising over $30,000 in the first ... that grows nutritious veggies & herbs fast, easy, and affordably, anywhere. , “Simply ...
(Date:3/22/2017)... ... March 21, 2017 , ... ... peristaltic pump with patented ReNu single-use (SU) cartridge technology. Engineered by the ... feed pumps in SU tangential flow filtration (TFF), virus filtration (VF) and ...
(Date:3/22/2017)... , ... March 22, 2017 , ... The Society for ... agencies as outlined in the Administration’s recently published fiscal year 2018 budget request. ... Institutes of Health (NIH) by $5.8 billion or roughly 20% of its total budget. ...
(Date:3/22/2017)... and PETACH TIKVAH, Israel ... (NASDAQ: BCLI), a leading developer of adult stem cell ... Lebovits , Chief Executive Officer, will provide an update ... Associates 2 nd Annual Neuroscience Biopartnering and Investment ... the New York Academy of Sciences. ...
Breaking Biology Technology:
(Date:2/27/2017)... , Feb. 27, 2017   Strategic Cyber Ventures ... it has led a $3.5 million investment in  Polarity ... Strategic Cyber Ventures is DC based and is led ... Hank Thomas . Ron Gula , also a ... also participated in this series A round of funding. ...
(Date:2/22/2017)... 2017 With the biometrics market to ... four technologies that innovative and agile startups must ... in the changing competitive landscape: multifactor authentication (MFA), ... "Companies can no longer afford to ... Dimitrios Pavlakis , Industry Analyst at ABI ...
(Date:2/16/2017)... 2017  Genos, a community for personal genetic ... received Laboratory Accreditation from the College of American ... laboratories that meet stringent requirements around quality, accuracy ... "Genos is committed to maintaining the ... honored to be receiving CAP accreditation," said ...
Breaking Biology News(10 mins):